Berlin Cures hat auf seiner Webseite den momentanen Stand der laufenden Zulassungsverfahren für #BC007 aktualisiert.

Der Beginn einer möglichen Phase III-Studie für #LongCOVID scheint jetzt erst für Q2 2025 vorgesehen zu sein.

First results of #BC007 by Berlin Cures targeting #LongCovid will be expected by end of 2024.

News from Berlin Cures

New CEO and Phase II study for #BC007 in June. Initial results are expected in early 2024.

berlincures.com/en/news/new-ceo

Über eine mögliche Notfallzulassung von #BC007 für #LongCOVID scheint Berlin Cures derzeit keine Angaben machen zu können.

Long COVID Stefan Homburg Michael Wiesmann 🇺🇦📯 Tobias Ulbrich Was ist BC007?

Ron Davis: '25% #MECFS patients have MS.'

GeNeuro: '25% of longhaulers have a reactivation of the HERV-W protein.'

My logic:
In ME: EBV reactivates HERV-W, and this leads to MS.
In LC: Sars-Cov-2 leads to EBV reactivation, EBV reactivates HERV-W, resulting in MS.

#LongCovid

Die phase 2 Studie für Bc007 beginnt endlich.

Start trials BC007

berliner-zeitung.de/gesundheit-oek…

Berlin Cures will start their phase II trial on BC007 for #LongCovid in June. First results are expected at the beginning of next year!

Phase II study for BC 007 for Long COVID to start in June

“Berlin Cures has received regulatory approvals to start a European multicenter Phase I clinical trial in the indication #LongCOVID with the molecule #BC007 and will begin the trial this June”

berlincures.com/en/news/new-ceo

In addition to BC007, CST-2032 and CST-13 appear to have the potential to improve cognitive function by improving cerebral perfusion.

Ok, just a thought. If BC007 phase 2 results look as promising as the ‘21 tests did, I think we should plan protests in Berlin to demand emergency funding & approval/access. It won’t be easy & it will require that friends & family get on board, but it could be worth a shot.

My favorites: bubble candles, a miracle washing machine cleaner, genius silverware storage, and Amazon's most perfect leggings with 70K+ reviews.

No mention of C19 here but targeted removal of pathogenic AAB’s is the purported mechanism by which BC007 may treat #LongCovid . Given the endless delays that have plagued its development it’s good to know that better-resourced/managed companies are working on similar technology.

I need bc007 now...but hopefully it is on the market in one year, unrealistic but you can never know...

berlincures.com/en/news/new-ceo
Bettina Stark-Watzinger Prof. Karl Lauterbach BMBF Bundesgesundheitsministerium

Bc007 is a joke

Brad Besides GPRC autoantibodies, there is so much more. And BC007 has multiple modes of action.

twitter.com/DinoWithLC/sta…

Berlin Cures has uploaded a new article about the appointment of their new CEO, Dr. Oliver von Stein.

The article also confirms that the Phase II-clinical trial with #BC007 for #LongCOVID will start this month.

berlincures.com/en/news/new-ceo

Why does the official website show that BC007 heart failure is in the third phase of clinical trials? Is it real?

Agy Lena 🏳️‍🌈 BC007 is on the way for you 🙏

Enhanced networking and access to new research first is what ISMB/ECCB 2023 is all about.

News von BC007:
'Berlin Cures has received regulatory approvals to start a European multicenter Phase II clinical trial in the indication Long COVID with the molecule BC 007 and will begin the trial this June'
'Initial results are expected in early 2024.'
berlincures.com/en/news/new-ceo

What is this bullshit about BC007 being delayed until 2025. Like are you serious 💀💀💀